ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260693.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.003933186	Resistant
ENSG00000260693.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.028745975	Resistant